Life science company Chiral Quest this week announced that the
non-profit organisation, the Penn State Research Foundation, has
received a US patent covering the compositions of matter and use
for a series of chiral phosphine ligands...
Two British firms, De Novo Pharmaceuticals and Peakdale Molecular,
are to enter into a joint collaboration to exploit their respective
skills in molecular design and chemistry synthesis, writes market
analysts Datamonitor this week.
As the lead story today on In-Pharmatechnologist.com
highlights, the European brain-drain is far from slowing down with
the US continuing to attract researchers and entrepreneurs. A fact
that has had, and will continue to have, a...
Sweden's Biacore International, a specialist in surface plasmon
resonance technologies, has launched its Biacore 3000 GxP (Good
Manufacturing Practice/Good Laboratory Practice) Package, which
will strengthen the system's...
Shareholders at Swiss pharmaceutical company Roche welcomed the
start of a new era as the company summarised recent events,
including the divestment of the vitamins business, at its annual
general meeting yesterday.
Maintaining sterility is a costly process for drug manufacturers,
but US company Pall Corp says it has introduced a new device that
will allow biopharmaceutical producers to make aseptic connections
instantly, reaping large savings...
The bulk of biotech companies are firmly rooted towards the foot of
the ladder of corporate evolution. Precious few can realistically
claim to be at the top end of the evolutionary scale with full
R&D capabilities, global reach...
Until recently nanotechnologists -- scientists who build devices
and materials one atom or molecule at a time -- concentrated almost
entirely on electronics, computers, telecommunications, and
materials manufacture. Now biomedical...
The Portuguese Minister for Science and Higher Education, Pedro
Lynce, confirmed his government's commitment to investing in
science with the announcement today that the ministry is
considering opening 20 new Ciência Viva (Science...
GlaxoSmithKline has entered into a new drug formulation agreement
with Flamel Technologies of France that could see the latter firm
receive up to $45 million (€41.3m) in licensing fees and milestone
The Eurobarometer 2002 survey on 'Europeans and biotechnology'
reveals that despite the impression that Europeans are sceptical
about this technology, the majority are optimistic that
biotechnololgy will improve our way...
Dow Chemical has agreed for Dowpharma, Dow's pharmaceutical
manufacturing services business unit, to supply select, proprietary
oligonucleotides to Montreal, Canada-based Topigen Pharmaceuticals
for use in its pharmaceutical...